Osteoporosis, Post-Menopausal: Clinical Trials

3 completed. 3 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	3	Completed 3

Follow Osteoporosis, Post-Menopausal: new trials by email Literature Review of Osteoporosis, Post-Menopausal trials Research Report on Osteoporosis, Post-Menopausal

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis teriparatide - Osteoporosis, Post-Menopausal	Phase 3	Completed	Eli Lilly and Company	50	2003-11-01	2007-09-20
A Study of the Treatment of Postmenopausal Women With Osteoporosis teriparatide 20 micrograms/day subcutaneous, salmon calcitonin 100 IU/day subcutaneous - Osteoporosis, Post-Menopausal	Phase 3	Completed	Eli Lilly and Company	104	2003-06-01	2007-10-12
PTH Comparison in Post Menopausal Women teriparatide 20 micrograms/day subcutaneous, calcitonin 100 IU/day subcutaneous - Osteoporosis, Post-Menopausal	Phase 3	Completed	Eli Lilly and Company	63	2002-12-01	2007-10-12

Narrower conditions

Osteoporosis, Postmenopausal (3)

Broader conditions

Bone Diseases (3)  ·  Bone Diseases, Metabolic (3)  ·  Metabolic Diseases (3)  ·  Musculoskeletal Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Osteoporosis (3)

Interventions

Teriparatide (3)  ·  Injections, Subcutaneous (2)  ·  Calcitonin (1)  ·  salmon calcitonin (1)

Sponsors

Eli Lilly and Company (3)

Countries

China (1)  ·  Russia (1)  ·  Taiwan (1)